Jorge Sanchez

7PUBLICATIONS
77CO-AUTHORS
Innate immunityEpidemiological methodsMedical infection agents (incl. prions)Disease surveillancePreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 04, 2026
Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections.

|Sep 15, 2026
Comparing Approaches for Estimating Counterfactual HIV Incidence Among Populations With High Vulnerability to HIV in Lima, Peru: A Multi-Study Comparative Analysis.

|Jul 14, 2026
Preferences for mHealth Features to Support Engagement in the HIV Preexposure Prophylaxis Cascade Among Men Who Have Sex With Men in Peru: Cross-Sectional Online Survey.

|May 01, 2026
An Ecological Momentary Assessment Smartphone App for High-Risk HIV Populations: Development and Usability Study.

|Jan 06, 2026
Implementation of Daily Oral PrEP at HIV/AIDS Service Organizations in Lima, Peru: Early Findings From the PrEP PERU Demonstration Study.

Pamela Ramírez, Alexander J Lankowski, Jorge A Gallardo-Cartagena

|Nov 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Bruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells

Pageof 2

Frequent Collaborators

4 joint publications

Javier R Lama

3 joint publications

Pedro Gonzales

2 joint publications

Jorge A Gallardo-Cartagena

2 joint publications

Frederick L Altice